Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine

다국어 초록 (Multilingual Abstract)

Breast cancer is a significant cause of cancer-related mortality in women worldwide. Early and precise diagnosis is crucial, and clinical outcomes can be markedly enhanced. The rise of artificial intelligence (AI) has ushered in a new era, notably in image analysis, paving the way for major advancements in breast cancer diagnosis and individualized treatment regimens. In the diagnostic workflow for patients with breast cancer, the role of AI encompasses screening, diagnosis, staging, biomarker evaluation, prognostication, and therapeutic response prediction. Although its potential is immense, its complete integration into clinical practice is challenging. Particularly, these challenges include the imperatives for extensive clinical validation, model generalizability, navigating the “black-box” conundrum, and pragmatic considerations of embedding AI into everyday clinical environments. In this review, we comprehensively explored the diverse applications of AI in breast cancer care, underlining its transformative promise and existing impediments. In radiology, we specifically address AI in mammography, tomosynthesis, risk prediction models, and supplementary imaging methods, including magnetic resonance imaging and ultrasound. In pathology, our focus is on AI applications for pathologic diagnosis, evaluation of biomarkers, and predictions related to genetic alterations, treatment response, and prognosis in the context of breast cancer diagnosis and treatment. Our discussion underscores the transformative potential of AI in breast cancer management and emphasizes the importance of focused research to realize the full spectrum of benefits of AI in patient care.

참고문헌 (Reference)

• 1 Kohli A, "Why CAD failed in mammography" 15 : 535-537, 2018
• 2 World Health Organization, "WHO position paper on mammography screening"
• 3 Yamamoto S, "Variability in measuring the Ki-67 labeling index in patients with breast cancer" 15 : e35-e39, 2015
• 4 Elmore JG, "Variability in interpretive performance at screening mammography and radiologists’ characteristics associated with accuracy" 253 : 641-651, 2009
• 5 Acs B, "Variability in breast cancer biomarker assessment and the effect on oncological treatment decisions : a nationwide 5-year population-based study" 13 : 1166-, 2021
• 6 Caldonazzi N, "Value of artificial intelligence in evaluating lymph node metastases" 15 : 2491-, 2023
• 7 Furrer D, "Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens" 8 : 17-, 2013
• 8 Sandbank J, "Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies" 8 : 129-, 2022
• 9 Cossío F, "VAI-B : a multicenter platform for the external validation of artificial intelligence algorithms in breast imaging" 10 : 061404-, 2023
• 10 Ren J, "Unsupervised domain adaptation for classification of histopathology whole-slide images" 7 : 102-, 2019
• 11 Mutasa S, "Understanding artificial intelligence based radiology studies : what is overfitting?" 65 : 96-99, 2020
• 12 Seyyed-Kalantari L, "Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations" 27 : 2176-2182, 2021
• 13 Denkert C, "Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer" 28 : 105-113, 2010
• 14 Metter DM, "Trends in the US and Canadian pathologist workforces from 2007 to 2017" 2 : e194337-, 2019
• 15 Lee CK, "Trastuzumab plus FOLFOX for gemcitabine/cisplatin refractory HER2-positive biliary tract cancer: a multi-institutional phase II trial of the Korean Cancer Study Group (KCSG-HB19-14)" 40 : 4096-, 2022
• 16 Yala A, "Toward robust mammography-based models for breast cancer risk" 13 : eaba4373-, 2021
• 17 Ghassemi M, "The false hope of current approaches to explainable artificial intelligence in health care" 3 : e745-e750, 2021
• 18 Marmot MG, "The benefits and harms of breast cancer screening : an independent review" 108 : 2205-2240, 2013
• 19 Gilbert FJ, "The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme--a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone" 19 : 1-136, 2015
• 20 Krag DN, "Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial" 8 : 881-888, 2007
• 21 Bakker MF, "Supplemental MRI screening for women with extremely dense breast tissue" 381 : 2091-2102, 2019
• 22 Yoon JH, "Standalone AI for breast cancer detection at screening digital mammography and digital breast tomosynthesis : a systematic review and meta-analysis" 307 : e222639-, 2023
• 23 Kim S, "Spatial analysis of tumor-infiltrating lymphocytes(TILs)based on HER2 expression across multiple cancer types" 10 : A1-A1603, 2022
• 24 Gilbert FJ, "Single reading with computer-aided detection for screening mammography" 359 : 1675-1684, 2008
• 25 Sophia K. Apple, "Sentinel Lymph Node in Breast Cancer: Review Article from a Pathologist’s Point of View" 대한병리학회 50 (50): 83-95, 2016
• 26 Amgad M, "Report on computational assessment of tumor infiltrating lymphocytes from the international immuno-oncology biomarker working group" 6 : 16-, 2020
• 27 Salim M, "Range of radiologist performance in a population-based screening cohort of 1 million digital mammography examinations" 297 : 33-39, 2020
• 28 The Royal College of Radiologists, "RCR Clinical Radiology Workforce Census 2022" The Royal College of Radiologists 2022
• 29 Whitney J, "Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer" 18 : 610-, 2018
• 30 de Jong VM, "Prognostic value of stromal tumor-infiltrating lymphocytes in young, node-negative, triple-negative breast cancer patients who did not receive (neo) adjuvant systemic therapy" 40 : 2361-2374, 2022
• 31 Hou R, "Prediction of upstaging in ductal carcinoma in situ based on mammographic radiomic features" 303 : 54-62, 2022
• 32 Qu YH, "Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method" 11 : 651-658, 2020
• 33 Wang X, "Prediction of BRCA gene mutation in breast cancer based on deep learning and histopathology images" 12 : 661109-, 2021
• 34 Krishnamurthy S, "Predicting response of triple-negative breast cancer to neoadjuvant chemotherapy using a deep convolutional neural network-based artificial intelligence tool" 7 : e2200181-, 2023
• 35 Veta M, "Predicting breast tumor proliferation from whole-slide images : the TUPAC16 challenge" 54 : 111-121, 2019
• 36 Zhang T, "Predicting breast cancer types on and beyond molecular level in a multi-modal fashion" 9 : 16-, 2023
• 37 Kos Z, "Pitfalls in assessing stromal tumor infiltrating lymphocytes(sTILs)in breast cancer" 6 : 17-, 2020
• 38 Kim M, "Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma : KCSG GU18-18" 8 : 101588-, 2023
• 39 Elston CW, "Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up" 19 : 403-410, 1991
• 40 Kather JN, "Pan-cancer image-based detection of clinically actionable genetic alterations" 1 : 789-799, 2020
• 41 Lee SE, "One-on-one comparison between conventional CAD and AI-CAD applied to screening mammography" 20 : 19-29, 2023
• 42 Lu C, "Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers" 98 : 1438-1448, 2018
• 43 Rexhepaj E, "Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry : application to measurement of oestrogen and progesterone receptor levels in breast cancer" 10 : R89-, 2008
• 44 Abele N, "Noninferiority of artificial intelligence-assisted analysis of Ki-67 and estrogen/progesterone receptor in breast cancer routine diagnostics" 36 : 100033-, 2023
• 45 Sun L, "Multi-view convolutional neural networks for mammographic image classification" 7 : 126273-126282, 2019
• 46 Sammut SJ, "Multi-omic machine learning predictor of breast cancer therapy response" 601 : 623-629, 2022
• 47 Roux L, "Mitosis detection in breast cancer histological images an ICPR 2012 contest" 4 : 8-, 2013
• 48 Sebai M, "MaskMitosis: a deep learning framework for fully supervised, weakly supervised, and unsupervised mitosis detection in histopathology images" 58 : 1603-1623, 2020
• 49 Boyd NF, "Mammographic density and the risk and detection of breast cancer" 356 : 227-236, 2007
• 50 Meti N, "Machine learning frameworks to predict neoadjuvant chemotherapy response in breast cancer using clinical and pathological features" 5 : 66-80, 2021
• 51 Zhou LQ, "Lymph node metastasis prediction from primary breast cancer US images using deep learning" 294 : 19-28, 2020
• 52 Acs B, "Ki67 reproducibility using digital image analysis : an inter-platform and inter-operator study" 99 : 107-117, 2019
• 53 Yerushalmi R, "Ki67 in breast cancer : prognostic and predictive potential" 11 : 174-183, 2010
• 54 Gastounioti A, "Is it time to get rid of black boxes and cultivate trust in AI?" 2 : e200088-, 2020
• 55 Hickman S, "Investigating a stand-alone ai system prompt accuracy for interval cancer detection in screening mammography"
• 56 Wanders AJ, "Interval cancer detection using a neural network and breast density in women with negative screening mammograms" 303 : 269-275, 2022
• 57 Sung Hun Kim ; Eun Hye Lee ; 전재관 ; You Me Kim ; Yun-Woo Chang ; Jin Hwa Lee ; Hye-Won Kim ; Eun Jung Choi ; the Alliance for Breast Cancer Screening in Korea (ABCS-K), "Interpretive Performance and Inter-Observer Agreement on Digital Mammography Test Sets" 대한영상의학회 20 (20): 218-224, 2019
• 58 Diaz LK, "Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer : a comparison of manual and computer-assisted scoring methods" 8 : 23-27, 2004
• 59 Swisher SK, "Interobserver agreement between pathologists assessing tumor-infiltrating lymphocytes (TILs) in breast cancer using methodology proposed by the international TILs working group" 23 : 2242-2248, 2016
• 60 McKinney SM, "International evaluation of an AI system for breast cancer screening" 577 : 89-94, 2020
• 61 Redondo A, "Inter-and intraradiologist variability in the BI-RADS assessment and breast density categories for screening mammograms" 85 : 1465-1470, 2012
• 62 Shafi S, "Integrating and validating automated digital imaging analysis of estrogen receptor immunohistochemistry in a fully digital workflow for clinical use" 13 : 100122-, 2022
• 63 Fenton JJ, "Influence of computer-aided detection on performance of screening mammography" 356 : 1399-1409, 2007
• 64 Niraula S, "Incidence, characteristics, and outcomes of interval breast cancers compared with screening-detected breast cancers" 3 : e2018179-, 2020
• 65 Conant EF, "Improving accuracy and efficiency with concurrent use of artificial intelligence for digital breast tomosynthesis" 1 : e180096-, 2019
• 66 Wang Y, "Improved breast cancer histological grading using deep learning" 33 : 89-98, 2022
• 67 Dembrower K, "Implications for downstream workload based on calibrating an artificial intelligence detection algorithm by standalone-reader or combined-reader sensitivity matching" 10 : S22405-, 2023
• 68 Rose SL, "Implementation of breast tomosynthesis in a routine screening practice : an observational study" 200 : 1401-1408, 2013
• 69 Steiner DF, "Impact of deep learning assistance on the histopathologic review of lymph nodes for metastatic breast cancer" 42 : 1636-1646, 2018
• 70 Vilmun BM, "Impact of adding breast density to breast cancer risk models : a systematic review" 127 : 109019-, 2020
• 71 Debien V, "Immunotherapy in breast cancer : an overview of current strategies and perspectives" 9 : 7-, 2023
• 72 Rasmusson A, "Immunogradient indicators for antitumor response assessment by automated tumor-stroma interface zone detection" 190 : 1309-1322, 2020
• 73 Krizhevsky A, "ImageNet classification with deep convolutional neural networks" 60 : 84-90, 2017
• 74 Couture HD, "Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype" 4 : 30-, 2018
• 75 Wolff AC, "Human epidermal growth factor receptor 2 testing in breast cancer : American Society of Clinical Oncology-College of American Pathologists guideline update" 147 : 993-1000, 2023
• 76 Wang X, "How can artificial intelligence models assist PD-L1 expression scoring in breast cancer : results of multi-institutional ring studies" 7 : 61-, 2021
• 77 Picard JD, "History of mammography" 182 : 1613-1620, 1998
• 78 Conde-Sousa E, "HEROHE challenge : predicting HER2 status in breast cancer from hematoxylin-eosin whole-slide imaging" 8 : 213-, 2022
• 79 Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 71 : 209-249, 2021
• 80 Jose L, "Generative adversarial networks in digital pathology and histopathological image processing : a review" 12 : 43-, 2021
• 81 Paik S, "Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer" 24 : 3726-3734, 2006
• 82 Dalmış MU, "Fully automated detection of breast cancer in screening MRI using convolutional neural networks" 5 : 014502-, 2018
• 83 Fernandez AI, "Examination of low ERBB2 protein expression in breast cancer tissue" 8 : 1-4, 2022
• 84 Han SS, "Evaluation of artificial intelligence-assisted diagnosis of skin neoplasms: a single-center, paralleled, unmasked, randomized controlled trial" 142 : 2353-2362.e2, 2022
• 85 Allison KH, "Estrogen and progesterone receptor testing in breast cancer : ASCO/CAP guideline update" 38 : 1346-1366, 2020
• 86 Lee H, "Enhancing breast cancer risk prediction by incorporating prior images" Springer Nature Switzerland 2023
• 87 Kim YG, "Effectiveness of transfer learning for enhancing tumor classification with a convolutional neural network on frozen sections" 10 : 21899-, 2020
• 88 Fenton JJ, "Effectiveness of computer-aided detection in community mammography practice" 103 : 1152-1161, 2011
• 89 Dembrower K, "Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload : a retrospective simulation study" 2 : e468-e474, 2020
• 90 Cardoso F, "Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up" 30 : 1194-1220, 2019
• 91 Taylor-Phillips S, "Double reading in breast cancer screening : cohort evaluation in the CO-OPS trial" 287 : 749-757, 2018
• 92 Obermeyer Z, "Dissecting racial bias in an algorithm used to manage the health of populations" 366 : 447-453, 2019
• 93 Niazi MK, "Digital pathology and artificial intelligence" 20 : e253-e261, 2019
• 94 Brügmann A, "Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains" 132 : 41-49, 2012
• 95 Gur D, "Digital breast tomosynthesis : observer performance study" 193 : 586-591, 2009
• 96 Do YA, "Diagnostic performance of artificial intelligence-based computer-aided diagnosis for breast microcalcification on mammography" 11 : 1409-, 2021
• 97 Elmore JG, "Diagnostic concordance among pathologists interpreting breast biopsy specimens" 313 : 1122-1132, 2015
• 98 Ehteshami Bejnordi B, "Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer" 318 : 2199-2210, 2017
• 99 Lehman CD, "Diagnostic accuracy of digital screening mammography with and without computer-aided detection" 175 : 1828-1837, 2015
• 100 Kim KH, "Development of AI-powered imaging biomarker for breast cancer risk assessment on the basis of mammography alone" 39 : 10519-, 2021
• 101 Clarke GM, "Development and evaluation of a robust algorithm for computer-assisted detection of sentinel lymph node micrometastases" 59 : 116-128, 2011
• 102 Li C, "DeepMitosis: mitosis detection via deep detection, verification and segmentation networks" 45 : 121-133, 2018
• 103 Huang SC, "Deep neural network trained on gigapixel images improves lymph node metastasis detection in clinical settings" 13 : 3347-, 2022
• 104 Srinidhi CL, "Deep neural network models for computational histopathology : a survey" 67 : 101813-, 2021
• 105 Naik N, "Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains" 11 : 5727-, 2020
• 106 Cho SY, "Deep learning-based predictive biomarker for adjuvant chemotherapy in early-stage hormone receptor-positive breast cancer" 79 : 3144-, 2019
• 107 Shamai G, "Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer" 13 : 6753-, 2022
• 108 Farahmand S, "Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer" 35 : 44-51, 2022
• 109 Anand D, "Deep learning to estimate human epidermal growth factor receptor 2 status from hematoxylin and eosin-stained breast tissue images" 11 : 19-, 2020
• 110 Xue T, "Deep learning to automatically evaluate HER2 gene amplification status from fluorescence in situ hybridization images" 13 : 9746-, 2023
• 111 Hu Y, "Deep learning system for lymph node quantification and metastatic cancer identification from whole-slide pathology images" 24 : 868-877, 2021
• 112 Xu Z, "Deep learning predicts chromosomal instability from histopathology images" 24 : 102394-, 2021
• 113 Choi S, "Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer" 9 : 71-, 2023
• 114 Cho SY, "Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients" 11 : 17363-, 2021
• 115 LeCun Y, "Deep learning" 521 : 436-444, 2015
• 116 van Zelst JC, "Dedicated computer-aided detection software for automated 3D breast ultrasound; an efficient tool for the radiologist in supplemental screening of women with dense breasts" 28 : 2996-3006, 2018
• 117 Ahern CH, "Cost-effectiveness analysis of mammography and clinical breast examination strategies : a comparison with current guidelines" 18 : 718-725, 2009
• 118 Ha R, "Convolutional neural network using a breast MRI tumor dataset can predict oncotype Dx recurrence score" 49 : 518-524, 2019
• 119 Masotti M, "Computer-aided mass detection in mammography : false positive reduction via gray-scale invariant ranklet texture features" 36 : 311-316, 2009
• 120 Rai PD, "Comparison of various scoring systems by immunohistochemistry for evaluating hormone receptors (estrogen receptor and progesterone receptor) in carcinoma of breast" 15 : 202-208, 2020
• 121 Weaver DL, "Comparison of pathologist-detected and automated computer-assisted image analysis detected sentinel lymph node micrometastases in breast cancer" 16 : 1159-1163, 2003
• 122 Arasu VA, "Comparison of mammography AI algorithms with a clinical risk model for 5-year breast cancer risk prediction : an observational study" 307 : e222733-, 2023
• 123 Lee HN, "Comparison of mammographic density estimation by Volpara software with radiologists’ visual assessment : analysis of clinical-radiologic factors affecting discrepancy between them" 56 : 1061-1068, 2015
• 124 Huynh BQ, "Comparison of breast DCE-MRI contrast time points for predicting response to neoadjuvant chemotherapy using deep convolutional neural network features with transfer learning" SPIE 2017
• 125 Green J, "Cohort profile : the million women study" 48 : 28-29e, 2019
• 126 Zardavas D, "Clinical management of breast cancer heterogeneity" 12 : 381-394, 2015
• 127 Gail MH, "Choosing breast cancer risk models : importance of independent validation" 112 : 433-435, 2020
• 128 Kim HE, "Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study" 2 : e138-e148, 2020
• 129 김영곤 ; 송인혜 ; 이현나 ; 김성철 ; 양동현 ; 김남국 ; 신동호 ; 유연수 ; 이교운 ; 김다혜 ; 정휘진 ; 조현빈 ; 이현규 ; 김태우 ; 최종현 ; 서창원 ; 한성일 ; 이영제 ; 이영서 ; 유형련 ; 이용주 ; 박정환 ; 오소희 ; 공경엽, "Challenge for Diagnostic Assessment of Deep Learning Algorithm for Metastases Classification in Sentinel Lymph Nodes on Frozen Tissue Section Digital Slides in Women with Breast Cancer" 대한암학회 52 (52): 1103-1111, 2020
• 130 Rodriguez-Ruiz A, "Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study" 29 : 4825-4832, 2019
• 131 Kim J, "Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer" 14 : R102-, 2012
• 132 Tice JA, "Breast density and benign breast disease : risk assessment to identify women at high risk of breast cancer" 33 : 3137-3143, 2015
• 133 Giuliano AE, "Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual" 67 : 290-303, 2017
• 134 Gradishar WJ, "Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology" 20 : 691-722, 2022
• 135 Giaquinto AN, "Breast cancer statistics, 2022" 72 : 524-541, 2022
• 136 Friedewald SM, "Breast cancer screening using tomosynthesis in combination with digital mammography" 311 : 2499-2507, 2014
• 137 Han Z, "Breast cancer multi-classification from histopathological images with structured deep learning model" 7 : 4172-, 2017
• 138 Taylor C, "Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993–2015: population based observational cohort study" 381 : e074684-, 2023
• 139 Samala RK, "Breast cancer diagnosis in digital breast tomosynthesis : effects of training sample size on multi-stage transfer learning using deep neural nets" 38 : 686-696, 2019
• 140 Humphries MP, "Automated tumour recognition and digital pathology scoring unravels new role for PD-L1 in predicting good outcome in ER-/HER2+ breast cancer" 2018 : 2937012-, 2018
• 141 Romo-Bucheli D, "Automated tubule nuclei quantification and correlation with oncotype DX risk categories in ER+ breast cancer whole slide images" 6 : 32706-, 2016
• 142 Turbin DA, "Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases" 110 : 417-426, 2008
• 143 Faratian D, "Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies : the TEAM Trial Experience" 55 : 587-593, 2009
• 144 Zakrzewski F, "Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues" 9 : 8231-, 2019
• 145 Nagi J, "Automated breast profile segmentation for ROI detection using digital mammograms" IEEE 87-92, 2010
• 146 Holm J, "Associations of breast cancer risk prediction tools with tumor characteristics and metastasis" 34 : 251-258, 2016
• 147 Wang H, "Association of machine learning ultrasound radiomics and disease outcome in triple negative breast cancer" 12 : 152-164, 2022
• 148 Gokhale S, "Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma" 15 : 451-455, 2007
• 149 Bolton KL, "Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies" 19 : 992-999, 2010
• 150 Kim G, "Assessing risk of breast cancer : a review of risk prediction models" 3 : 144-155, 2021
• 151 Shin S, "Artificial intelligence–powered tumor-infiltrating lymphocytes analyzer to reveal distinct immune landscapes in breast cancer by molecular subtype and HER2 score" 41 : 1049-, 2023
• 152 Lång K, "Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study" 24 : 936-944, 2023
• 153 Jung M, "Artificial intelligence-powered human epidermal growth factor receptor 2 (HER2) analyzer in breast cancer as an assistance tool for pathologists to reduce interobserver variation" 40 : e12543-, 2022
• 154 Mahmood T, "Artificial intelligence-based mitosis detection in breast cancer histopathology images using faster R-CNN and deep CNNs" 9 : 749-, 2020
• 155 Albusayli R, "Artificial intelligence-based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease-specific survival in triple-negative breast cancer" 260 : 32-42, 2023
• 156 Liu Y, "Artificial intelligence-based breast cancer nodal metastasis detection : insights into the black box for pathologists" 143 : 859-868, 2019
• 157 Shen Y, "Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams" 12 : 5645-, 2021
• 158 Huang Z, "Artificial intelligence reveals features associated with breast cancer neoadjuvant chemotherapy responses from multi-stain histopathologic images" 7 : 14-, 2023
• 159 Badve SS, "Artificial intelligence in breast pathology-dawn of a new era" 9 : 5-, 2023
• 160 Polónia A, "Artificial intelligence improves the accuracy in histologic classification of breast lesions" 155 : 527-536, 2021
• 161 Kann BH, "Artificial intelligence for clinical oncology" 39 : 916-927, 2021
• 162 Dembrower K, "Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study" 5 : E703-E711, 2023
• 163 Shamai G, "Artificial intelligence algorithms to assess hormonal status from tissue microarrays in patients with breast cancer" 2 : e197700-, 2019
• 164 Imai M, "Artificial intelligence (AI)-powered HER2 quantification continuous score (QCS) and tumor microenvironment (TME) analysis in HER2-amplified metastatic colorectal cancer (mCRC) treated with pertuzumab plus trastuzumab" 9 : 34-, 2023
• 165 Cho SY, "Artificial intelligence (AI) - powered human epidermal growth factor receptor-2 (HER2) and tumor-infiltrating lymphocytes (TIL) analysis for HER2-positive early breast cancer patients treated with HER2-targeted neoadjuvant chemotherapy (NAC)" 33 : S610-, 2022
• 166 장윤우 ; 안진경 ; 최나미 ; 고경희 ; 김기환 ; 한경화 ; 류정규, "Artificial Intelligence for Breast Cancer Screening in Mammography (AI-STREAM): A Prospective Multicenter Study Design in Korea Using AI-Based CADe/x" 한국유방암학회 25 (25): 57-68, 2022
• 167 U.S. Food and Drug Administration (FDA), "Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices"
• 168 Liu Y, "Applications of artificial intelligence in breast pathology" 147 : 1003-1013, 2023
• 169 Qian L, "Application of deep learning to predict underestimation in ductal carcinoma in situ of the breast with ultrasound" 9 : 295-, 2021
• 170 Holten-Rossing H, "Application of automated image analysis reduces the workload of manual screening of sentinel lymph node biopsies in breast cancer" 71 : 866-873, 2017
• 171 Giger ML, "Anniversary paper : history and status of CAD and quantitative image analysis : the role of Medical Physics and AAPM" 35 : 5799-5820, 2008
• 172 Polley MY, "An international Ki67 reproducibility study" 105 : 1897-1906, 2013
• 173 Saslow D, "American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography" 57 : 75-89, 2007
• 174 Knoll F, "Advancing machine learning for MR image reconstruction with an open competition : overview of the 2019 fastMRI challenge" 84 : 3054-3070, 2020
• 175 Hickman SE, "Adoption of artificial intelligence in breast imaging: evaluation, ethical constraints and limitations" 125 : 15-22, 2021
• 176 Harbeck N, "Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer : updated efficacy and Ki-67 analysis from the monarchE study" 32 : 1571-1581, 2021
• 177 Cruz-Roa A, "Accurate and reproducible invasive breast cancer detection in whole-slide images : a deep learning approach for quantifying tumor extent" 7 : 46450-, 2017
• 178 Pantanowitz L, "Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses" 15 : 80-, 2020
• 179 Rajpurkar P, "AI in health and medicine" 28 : 31-38, 2022
• 180 El-Naqa I, "A support vector machine approach for detection of microcalcifications" 21 : 1552-1563, 2002
• 181 Lee B, "A robust and effective approach towards accurate metastasis detection and pN-stage classification in breast cancer" Springer Nature Switzerland 841-850, 2018
• 182 Abràmoff MD, "A reimbursement framework for artificial intelligence in healthcare" 5 : 72-, 2022
• 183 Ravichandran K, "A deep learning classifier for prediction of pathological complete response to neoadjuvant chemotherapy from baseline breast DCE-MRI" SPIE 2018
• 184 Romo-Bucheli D, "A deep learning based strategy for identifying and associating mitotic activity with gene expression derived risk categories in estrogen receptor positive breast cancers" 91 : 566-573, 2017
• 185 Nateghi R, "A deep learning approach for mitosis detection : application in tumor proliferation prediction from whole slide images" 114 : 102048-, 2021
• 186 Connor SJ, "A comparison of reading times in full-field digital mammography and digital breast tomosynthesis" 14 : P26-, 2012
• 187 "22nd International Conference on Pattern Recognition (ICPR)" MITOS & ATYPIA 14 Contest